Tilray Brands (TLRY) Deferred Taxes (2018 - 2026)
Tilray Brands' (TLRY) quarterly Deferred Taxes came in at $13.9 million in Q2 2026, up 111.21% YoY from $6.6 million in Q2 2025, and up 602.28% on a QoQ basis from $2.0 million in Q1 2026.
Tilray Brands (TLRY) Deferred Taxes (2018 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 9 years of Deferred Taxes data on file, last reported at $13.9 million in Q2 2026.
- Quarterly Deferred Taxes rose 111.21% year-over-year to $13.9 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $17.1 million (up 114.13% YoY) and the FY2026 annual result came in at $17.1 million, up 114.13% from the prior year.
- Deferred Taxes grew to $13.9 million in Q2 2026, from $2.0 million in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $13.9 million in Q2 2026 to a low of -$123.7 million in Q2 2025.
- A 5-year average of -$10.6 million and a median of -$2.4 million in 2023 frame the typical range for Deferred Taxes.
- The widest YoY moves for Deferred Taxes: up 547.46% in 2024, down 1202.69% in 2024.
- Tracing TLRY's Deferred Taxes over 5 years: stood at -$13.7 million in 2022, then soared by 70.15% to -$4.1 million in 2023, then surged by 127.97% to $1.1 million in 2024, then surged by 209.15% to $3.5 million in 2025, then soared by 290.95% to $13.9 million in 2026.
- The last three Deferred Taxes figures came in at $13.9 million (Q2 2026), $2.0 million (Q1 2026), and $3.5 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 25.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | -33.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 25.70 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -124.50 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | -25.30 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Tilray Brands | 519.72 Mn | 285.09 Mn | 90.52 Mn | 13.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 13.86 Mn |
| Feb 28, 2026 | 1.97 Mn |
| Nov 30, 2025 | 3.55 Mn |
| Aug 31, 2025 | -2.29 Mn |
| May 31, 2025 | -123.70 Mn |
| Feb 28, 2025 | 1.16 Mn |
| Nov 30, 2024 | 1.15 Mn |
| Aug 31, 2024 | 382,000.00 |
| May 31, 2024 | -31.47 Mn |
| Feb 29, 2024 | -3.36 Mn |
| Nov 30, 2023 | -4.10 Mn |
| Aug 31, 2023 | 59,000.00 |
| May 31, 2023 | -2.42 Mn |
| Feb 28, 2023 | -16.60 Mn |
| Nov 30, 2022 | -13.74 Mn |
| Aug 31, 2022 | 796,000.00 |
| May 31, 2022 | -10.24 Mn |
| Feb 28, 2022 | -6.07 Mn |
| Nov 30, 2021 | 13.65 Mn |
| Aug 31, 2021 | -24.87 Mn |